Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | M/s Shubham Medicals Port Blair | Awarded | 1 | ₹43,350 |
| 2 | Schedule 2 | M/s Shubham Medicals Port Blair | Awarded | 1 | ₹85,440 |
Tender Value
₹1.6 L
EMD Value
Exempted
Closing Date
20 Nov 2023, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
LEVOSALBUTAMOL AEROSOL PACK OF 200 METERED DOSE (Q3)
AMOXYCILLIN 875MG PLUS CLAVULANIC ACID 125MG (Q3)
5523006
GEM/2023/B/4142133
Two Packet Bid
LEVOSALBUTAMOL AEROSOL PACK OF 200 METERED DOSE,AMOXYCILLIN 875MG PLUS CLAVULANIC ACID 125MG
30 days
Andaman And Nicobar Islands; South Andamans
Item wise evaluation
PRODUCT_CUSTOM
6 documents required · 6 mandatory
3 yrs
₹3
40%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| LEVOSALBUTAMOL AEROSOL PACK OF 200 METERED DOSE (Q3) | SOUTH ANDAMAN | 510 | 30 days | - |
| AMOXYCILLIN 875MG PLUS CLAVULANIC ACID 125MG (Q3) | SOUTH ANDAMAN | 9,600 | 30 days |
Exempted
20 Nov 2023
10 Nov 2023
20 Nov 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5523006.pdf
GEM_BID
levosal_plus_1_2023-10-28-10-27-38_60d9aa4a4402fa92ed915c46a2eaf63a.pdf
SPECIFICATION
levosal_plus_1_2023-10-28-10-29-49_84949e63edbd86addadc45c826390a93.pdf
SPECIFICATION
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .